Full Press Release Details
BRIDGEWATER, N.J. , Nov. 2, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the following virtual investor conferences:
Each fireside chat will be webcast live and can be accessed by visiting the investor relations section of the company's website at www.insmed.com . Each webcast will be archived for a period of 30 days following the conclusion of each live event.
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States and the European Union to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey , with a growing footprint across Europe and in Japan . For more information, visit www.insmed.com .
Argot Partners Laura Perry or Heather Savelle (212) 600-1902 [email protected]
Mandy Fahey Senior Director, Corporate Communications Insmed (732) 718-3621 [email protected]
SOURCE Insmed Incorporated